tiprankstipranks
Trending News
More News >
ChemoMetec A/S (DE:CHY)
FRANKFURT:CHY
Advertisement

ChemoMetec A/S (CHY) Price & Analysis

Compare
6 Followers

CHY Stock Chart & Stats


CHY FAQ

What was ChemoMetec A/S’s price range in the past 12 months?
ChemoMetec A/S lowest stock price was €47.56 and its highest was €82.60 in the past 12 months.
    What is ChemoMetec A/S’s market cap?
    ChemoMetec A/S’s market cap is €1.26B.
      When is ChemoMetec A/S’s upcoming earnings report date?
      ChemoMetec A/S’s upcoming earnings report date is Nov 11, 2025 which is in 57 days.
        How were ChemoMetec A/S’s earnings last quarter?
        ChemoMetec A/S released its earnings results on Sep 11, 2025. The company reported -€0.139 earnings per share for the quarter, missing the consensus estimate of -€0.129 by -€0.011.
          Is ChemoMetec A/S overvalued?
          According to Wall Street analysts ChemoMetec A/S’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does ChemoMetec A/S pay dividends?
            ChemoMetec A/S does not currently pay dividends.
            What is ChemoMetec A/S’s EPS estimate?
            ChemoMetec A/S’s EPS estimate is 0.5.
              How many shares outstanding does ChemoMetec A/S have?
              ChemoMetec A/S has 17,402,480 shares outstanding.
                What happened to ChemoMetec A/S’s price movement after its last earnings report?
                ChemoMetec A/S reported an EPS of -€0.139 in its last earnings report, missing expectations of -€0.129. Following the earnings report the stock price went down -0.601%.
                  Which hedge fund is a major shareholder of ChemoMetec A/S?
                  Currently, no hedge funds are holding shares in DE:CHY

                  Company Description

                  ChemoMetec A/S

                  ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal production; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. It also provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. The company was incorporated in 1997 and is headquartered in Allerød, Denmark.

                  ChemoMetec A/S (CHY) Earnings & Revenues

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis